6 years of historical data (2020–2025) · Healthcare · Medical - Devices
Percentile shows where the current value sits in 30-year historical distribution. Sparklines show 5-year trend.
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
Allurion Technologies Inc. currently has a negative P/E ratio, indicating the company is operating at a loss on a trailing-twelve-month basis.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|---|
| Market Cap | $4M | $9M | $24M | $133M | $272M | $13.2B | — |
| Enterprise Value | $28M | $33M | $47M | $137M | $324M | $13.2B | — |
| P/E Ratio → | -0.15 | — | — | — | — | — | — |
| P/S Ratio | 0.29 | 0.61 | 0.75 | 2.49 | 4.23 | 346.31 | — |
| P/B Ratio | — | — | — | — | — | — | — |
| P/FCF | — | — | — | — | — | — | — |
| P/OCF | — | — | — | — | — | — | — |
P/E links to full P/E history page with 30-year chart
Enterprise-value multiples — capital-structure-neutral measures of total business value
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 2.16 | 1.45 | 2.56 | 5.04 | 346.32 | — |
| EV / EBITDA | — | — | — | — | — | — | — |
| EV / EBIT | — | — | — | — | — | — | — |
| EV / FCF | — | — | — | — | — | — | — |
Margins and return-on-capital ratios measuring operating efficiency
Allurion Technologies Inc. earns an operating margin of -198.0%. Operating margins have compressed from -147.9% to -198.0% over the past 3 years, signaling potential cost pressures or competitive headwinds.
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|---|
| Gross Margin | 62.8% | 62.8% | 67.0% | 77.6% | 79.0% | 76.3% | — |
| Operating Margin | -198.0% | -198.0% | -156.3% | -147.9% | -49.9% | -32.7% | — |
| Net Profit Margin | -188.8% | -188.8% | -81.4% | -150.8% | -58.8% | -32.4% | — |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|---|
| ROE | — | — | — | — | — | — | -26.1% |
| ROA | -118.4% | -118.4% | -50.0% | -131.0% | -83.2% | -62.4% | -1.6% |
| ROIC | — | — | — | — | -122.9% | — | — |
| ROCE | — | — | -496.1% | -1257.8% | — | -322.2% | -26.1% |
Solvency and debt-coverage ratios — lower is generally safer
Net debt stands at $24M ($29M total debt minus $5M cash).
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|---|
| Debt / Equity | — | — | — | — | — | — | 8.57 |
| Debt / EBITDA | — | — | — | — | — | — | 0.85 |
| Net Debt / Equity | — | — | — | — | — | — | 6.20 |
| Net Debt / EBITDA | — | — | — | — | — | — | 0.61 |
| Debt / FCF | — | — | — | — | — | — | — |
| Interest Coverage | — | — | -10.23 | -6.60 | -7.50 | -2.38 | — |
Short-term solvency ratios and asset-utilisation metrics
The current ratio of 0.33x is below 1.0, meaning current liabilities exceed current assets. The current ratio has declined from 0.99x to 0.33x over the past 3 years.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|---|
| Current Ratio | 0.33 | 0.33 | 1.44 | 0.99 | 0.57 | 1.18 | 0.15 |
| Quick Ratio | 0.26 | 0.26 | 1.26 | 0.90 | 0.52 | 1.09 | 0.15 |
| Cash Ratio | 0.14 | 0.14 | 0.82 | 0.58 | 0.10 | 0.82 | 0.15 |
| Asset Turnover | — | 0.97 | 0.98 | 0.75 | 1.25 | 0.97 | — |
| Inventory Turnover | 2.12 | 2.12 | 3.12 | 1.94 | 3.49 | 3.33 | — |
| Days Sales Outstanding | — | 94.69 | 81.09 | 124.20 | 166.81 | 65.21 | — |
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Allurion Technologies Inc. does not currently pay a dividend and has no material buyback yield, reinvesting earnings back into the business.
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|---|
| Dividend Yield | — | — | — | — | — | — | — |
| Payout Ratio | — | — | — | — | — | — | — |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|---|
| Earnings Yield | — | — | — | — | — | — | — |
| FCF Yield | — | — | — | — | — | — | — |
| Buyback Yield | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | — |
| Total Shareholder Yield | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | — |
| Shares Outstanding | — | $8M | $2M | $1M | $1M | $54M | $108M |
Compare ALUR with 10 similar companies in its peer group
| Company | Market Cap | P/E | EV/EBITDA | P/FCF | Gross Margin | Op Margin | ROE | ROIC | Debt/EBITDA |
|---|---|---|---|---|---|---|---|---|---|
| $4M | -0.2 | — | — | 62.8% | -198.0% | — | — | — | |
| $62M | -0.5 | — | — | — | — | -744.2% | -1115.0% | — | |
| $2B | -11.7 | — | — | 74.5% | -23.5% | -38.9% | -16.4% | — | |
| $2B | 6.8 | 6.8 | 8.5 | 72.3% | 38.5% | 29.1% | 14.2% | 1.3 | |
| $320M | 45.0 | 27.6 | 28.9 | 78.1% | 15.4% | 17.2% | 26.1% | 0.0 | |
| $192B | 12.2 | 9.1 | 43.1 | 81.0% | 41.3% | 60.7% | 36.2% | 0.9 | |
| $1.0T | 47.8 | 34.3 | 115.6 | 83.8% | 45.6% | 101.2% | 41.8% | 1.4 | |
| $182B | 23.7 | 14.4 | 22.5 | 70.8% | 29.1% | 106.1% | 14.8% | 3.4 | |
| $8B | 69.5 | 55.1 | 105.3 | 73.8% | 4.5% | 25.2% | 8.6% | 7.9 | |
| $1B | -7.1 | 17.1 | 5.1 | 69.5% | -10.4% | -13.9% | -11.5% | 10.4 | |
| $2B | 3.6 | 2.6 | — | 93.7% | 50.1% | — | — | 0.4 | |
| Healthcare Median | — | 22.1 | 14.2 | 18.5 | 63.9% | -4.3% | -32.6% | -11.6% | 3.2 |
Peer selection based on competitive and market overlap. Compare multiple stocks →
Includes 30+ ratios · 6 years · Updated daily
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying ALUR stock.
Allurion Technologies Inc.'s current P/E ratio is -0.2x. This places it at the 50th percentile of its historical range.
Based on historical data, Allurion Technologies Inc. is trading at a P/E of -0.2x. This is at the 50th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.
Allurion Technologies Inc. has 62.8% gross margin and -198.0% operating margin.